Thursday | NOV 9, 2023 | 4:00 - 5:15 PM
Moderated by Rachael Manion
Topic: Skin of Color/Rare Skin Conditions
The Patient Research Engagement Workshop involved a panel discussion with two male patients with rare skin conditions. One of the patients lives with pemphigus vulgaris and the other with a burn injury he sustained on the job. Both patients discussed their skin conditions and what it was like for them trying to get a diagnosis and begin treatment.
Friday | NOV 10, 2023 | 4:00 - 5:15 PM
Speaker: Dr. Nitika Pai
Title: Oh Melanin- did you just skin me? Colorism and its impact on EDI in the workplace.
Dr Pai is a tenured Associate Professor in the Department of Medicine at McGill University and a Senior Scientist at MUHC Research Institute, Montreal, Canada.
Her global implementation research program on diagnostics is based in Canada, South Africa, and India. She is a global expert in point-of-care diagnostics, digital health, and implementation science in HIV/ STBBI (i.e., Hepatitis C, Hepatitis B, HPV, bacterial STIs) and sexual and reproductive health. She integrates rapid diagnostics with digital health solutions to plug health service delivery gaps. Using design thinking, she develops process and product innovations. She synergizes digital health, machine learning, and predictive analytics with rapid point-of-care diagnostics to impact clinical care and service delivery in community settings. Her solutions aim to generate clinical, public health, and social impact. They are being evaluated and implemented nationally & internationally.
Speaker: Dr. Diego Herrero
Title: Equity, Diversity and Inclusion. Approaches to Enhance Innovation and Social Relevance of Research Projects.
Diego Herrera, PhD works as Equity, Diversity and Inclusion (EDI) Specialist at the Research Institute of the McGill University Health Centre. He has worked for sixteen years as a researcher and practitioner with Indigenous peoples, women, displaced population, and youth affected by armed conflicts in seven countries. He has worked as EDI Advisor for Research at the University of Ottawa, as Program Specialist at UN Women Colombia and as Human Rights and Gender Equality Specialist at the Centre for International Studies and Cooperation (CECI) in Canada. He holds a PhD in intercultural communication and development from the University of Montreal and has worked as a researcher and lecturer in several Colombian and Canadian universities. He has also published several articles, books and book chapters related to his research and professional experience.
Lab Info
Name:
Biobank LOEX
Principal investigator:
Ms. Veronique Moulin
Location:
Quebec, Quebec
Contact:
Veronique Moulin
veronique.moulin@fmed.ulaval.ca
Objective/description
The advancement of biomedical research including regenerative medicine, tissue engineering reconstruction of different tissues and organs as well as the understanding of physiological, pathophysiological mechanisms and pharmacotoxicological and cosmetological analyzes.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
Lab Info
Name:
Piguet Lab
Principal investigator:
Dr. Vincent Piguet
Location:
Toronto, Ontario
Contact:
David Croitoru
David.croitoru@mail.utoronto.ca
Objective/description
We are engaged in translational research of inflammatory dermatoses and perturbation of immune regulation and microbial communities at associated disease sites.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
Lab Info
Name:
CTTB Biobank and Registry for Atopic dermatitis
Principal investigator:
Dr. Carolyn Jack
Location:
Montreal, Quebec
Contact:
Gaurav Isola
gaurav.isola@mail.mcgill.ca
Objective/description
The Transdisciplinary Centre for Biological Therapies (Centre Transdisciplinaire de Thérapies Biologiques or CTTB) is a multidisciplinary, integrated approach for patients who are receiving therapies directed at the immune system. The CTTB Biobank and Registry for Atopic dermatitis has been created to collect and store blood, skin tissue and other types of biological samples, as well as clinical information, for current and future research purposes.
Objectives:
To identify the impact of various treatments for dermatitis on patient symptoms, quality of life and disease outcome.
To characterize (including potential sequencing) skin lesions and matched normal tissues at the molecular and cellular level (the cells, the DNA, RNA and proteins, as well as their regulatory factors), to help better understand disease biology, prognosis and response to therapy, with a potential to identify new targets for improved treatments.
To characterize cells, proteins and genetic material (RNA and DNA) in the blood or other bodily fluids to identify characteristics that may act to identify specific kinds of skin diseases, or to predict response to therapy or disease outcome.
To characterize biomarkers, including those related to microbiome (bacteria that live on or in humans) to identify potential disease markers, markers of response to therapy or prognostic markers.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
This is a test